Planet Briefing

First published · Last updated

Hesperidin Enhances the Antitumor Effect of Gefitinib Against Non-Small Cell Lung Cancer via Activation of Endoplasmic Reticulum Stress

A journal article published by IMR Press reports that combining hesperidin with gefitinib increases antitumor activity against non-small cell lung cancer through activation of endoplasmic reticulum stress. The supplied source metadata includes only the publisher and content type without further study details.

Categories: science-and-space, public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence
5/10
Geographic reach
1/10
Global importance
3/10
Impact magnitude
3/10
Positivity
6/10
Urgency
1/10

Why it matters

The paper describes a potential therapeutic enhancement for non-small cell lung cancer treatment.

Sources

Report an issue